Heartsciences Inc (HSCS)

Jun 13, 2026

HSCS Q1 2026 Earnings: EPS Beat Surprise of 27% on Lower-Than-Expected Loss, No Revenue ReportedGrowth Acceleration Report - newsline.com

Jun 13, 2026

Jun 11, 2026

AI ECG heart test secures patent protection in 19 European countries - Stock Titan

Jun 11, 2026

Jun 10, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Jun 10, 2026

Jun 09, 2026

HeartSciences Inc. Financial Disclosures & SEC Filings - TradingView

Jun 09, 2026

Jun 05, 2026

HeartSciences Launches New Version of MyoVista Insights with AI-ECG - dicardiology.com

Jun 05, 2026

Jun 02, 2026

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm - The Manila Times

Jun 02, 2026

Jun 02, 2026

AI heart scan helping spot heart failure risk earns $136 Medicare payment - Stock Titan

Jun 02, 2026

May 29, 2026

HeartSciences Inc. (HSCS) Slides 6.96% as Stock Approaches Critical Support at $1.59Dealer Positioning - The Legal Advocate

May 29, 2026

May 28, 2026

HeartSciences Warrants (HSCSW) Remain Flat at $0.05 as Support and Resistance CoincideDark Pool Prints - newsline.com

May 28, 2026

May 27, 2026

HeartSciences Inc. (HSCS) Declines Over 7% as Stock Tests Key Support Near $1.70Early Entry Signals - The Legal Advocate

May 27, 2026

May 27, 2026

HSCS Q1 2026 Earnings: EPS Beat Amid Cost‑Discipline, but Revenue Void Weighs on SentimentTech Earnings Analysis - newsline.com

May 27, 2026

May 26, 2026

HeartSciences Inc. (HSCS) Slips 2.5% as Shares Test Key Support ZoneProfit Surge Picks - The Legal Advocate

May 26, 2026

May 25, 2026

HeartSciences Inc. Warrant (HSCSW) Slides 15.50% as Price Narrows to $0.05TPO Profile - The Legal Advocate

May 25, 2026

May 23, 2026

HeartSciences Inc. Warrant (HSCSW) Slides 15% as Price Hovers at Key $0.05 LevelPut Flow Alert - The Legal Advocate

May 23, 2026

May 22, 2026

HeartSciences Inc. (HSCS) Q1 2026 Earnings: Wider-Than-Expected Loss Narrows on Strong Cost Control, Shares RallyAdjusted Earnings Analysis - The Legal Advocate

May 22, 2026

May 21, 2026

HSCS Q1 2026 Earnings: EPS Surpasses Estimates as HeartSciences Advances Development PipelineEarnings Growth Analysis - newsline.com

May 21, 2026

May 19, 2026

HeartSciences signs North Shore Health for MyoVista platform - Investing.com UK

May 19, 2026

May 19, 2026

HeartSciences signs North Shore Health for MyoVista platform By Investing.com - Investing.com Nigeria

May 19, 2026

May 19, 2026

Rural Minnesota hospital adopts AI ECG platform endorsed by 127-hospital network - Stock Titan

May 19, 2026

May 18, 2026

HeartSciences (HSCS) Rallies +3.99% as Bulls Target $1.94 2026-05-18Undervalued Stocks - newsline.com

May 18, 2026

May 17, 2026

HeartSciences Stockholders Approve Director Election and Equity Plan - TipRanks

May 17, 2026

May 17, 2026

HeartSciences (HSCSW) Stalls at $0.06 — Breakout or Breakdown? 2026-05-17Fibonacci Entry Signals - newsline.com

May 17, 2026

May 15, 2026

HeartSciences (HSCS) Reports Strong Q1 2026 — Revenue $N/A, EPS BeatsMarket Hype Signals - newser.com

May 15, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 14, 2026

HeartSciences (HSCS) Stock: Slides -3.53%, Support at $1.74 2026-05-14Gamma Alerts - Newser

May 14, 2026

May 14, 2026

HeartSciences (HSCSW) Stalls at $$0.06 — Breakout or Breakdown? 2026-05-14Collaborative Trading Signals - newser.com

May 14, 2026

May 10, 2026

What HeartSciences (HSCS) accounting reveals about the business | Q1 2026: EPS Tops ViewsCommunity Volume Signals - newser.com

May 10, 2026

May 10, 2026

What HeartSciences (HSCSW) disclosed about liquidity position | HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataEarnings Risk - Newser

May 10, 2026

May 10, 2026

HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataQuarterly Financial Update - The Legal Advocate

May 10, 2026

May 08, 2026

The technology investments behind HeartSciences (HSCSW) growth | HSCSW Q1 Earnings: HeartSciences Revenue Data UnavailableFinancial Health - Newser

May 08, 2026

May 08, 2026

HSCSW HeartSciences quarterly results show strategic progress as innovation pipeline drives growth, CEO upbeat on outlook.Cyclicality - newser.com

May 08, 2026

May 07, 2026

HeartSciences Inc. 2026 Annual Meeting 8-K Filing: Company Details, Stockholder Votes, and Corporate Governance Updates - Minichart

May 07, 2026

May 06, 2026

HeartSciences (NASDAQ: HSCS) 2026 meeting backs director, auditor, adjournment - Stock Titan

May 06, 2026

May 05, 2026

HeartSciences signs first SaaS revenues agreement following full launch of MyoVista Insights(TM) - marketscreener.com

May 05, 2026

May 05, 2026

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - The Manila Times

May 05, 2026

May 05, 2026

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights - Weekly Voice

May 05, 2026

May 05, 2026

Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights - TradingView

May 05, 2026

May 05, 2026

Colorado hospital becomes first paying MyoVista Insights customer - Stock Titan

May 05, 2026

May 05, 2026

Heartsciences Signs Commercial Agreement with St. Vincent Health for MyoVista Insights SaaS Deployment - marketscreener.com

May 05, 2026

Apr 23, 2026

HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops ViewsDirect Listing - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026

Apr 23, 2026

HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly.Debt Refinancing - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 22, 2026

HSCS (HeartSciences) shares drop 3.2 percent despite Q1 2026 EPS beat as revenue plummets year over year.Dividend Suspension - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026